M. D'Elios, "Multiple sclerosis: the role of cytokines in pathogenesis and in therapies," International Journal of Molecular Sciences, vol. 13, pp. 13438-13460, 2012.Amedei A, Prisco D, D'Elios MM. Multiple sclerosis: The role of cytokines in pathogenesis and in therapies. Int J Mol ...
New therapies in multiple sclerosis - an evidencebased analysis - PC77 Romanian Journal of NeurologyMarginean, I.Vacaras, V.Popescu, D.Vicas, A.
Multiple sclerosis is currently incurable. But treatment focuses on quick recovery after flares, reducing the possibility of relapse, managing symptoms, and slowing disease progression. Treatments typically include corticosteroids, disease-modifying therapies (DMTs), and plasmapheresis (plasma exchange). ...
Children and teens with multiple sclerosis are treated with the same therapies as adults, but they are considered “off label” for treating children, (not an FDA approved the use of the drug, but it is/may be effective for some people with the condition). Small studies suggest the IV dru...
Investigational drug therapies for treatment of multiple sclerosis The licensing of interferon beta-1b dramatically changed the treatment of multiple sclerosis (MS) in the United States. Although it was the first therapeut... Hillel,S,Panitch - 《Mult Scler》 被引量: 3发表: 1996年 TERIFLUNOMIDE...
20. Therapies for multiple sclerosis 来自 Wiley 喜欢 0 阅读量: 34 作者: Bart M. Demaerschalk MD MSc FRCP(C) 摘要: Summary Multiple sclerosis (MS) is an idiopathic inflammatory demyelinating disease of the central nervous system. It is one of the leading causes of neurologic disability, ...
Multiple Sclerosis Novel Therapies for Multiple SclerosisNovel Therapies for Multiple Sclerosismultiple sclerosistherapymonoclonal antibodiesoral immunomodulatorsAs all currently approved drugs for treatment of multiple sclerosis (MS) are only partially effective and administered parenterally, the search for more...
Experimental Therapies for Multiple Sclerosis: Historical Perspective My task is to describe the evolution over the past 20 years of clinical trial designs in multiple sclerosis to their current state; to list major milestones as I see them; and to point out past, present, and future difficulties...
Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology a... Glucocorticoids: 1. On the basis of several and generally consistent Class I and Class II studies, glucocorticoid treatment has been demonstrated...
What is multiple sclerosis (MS)? MS is a disease that leads to inflammation and damage to parts of your central nervous system (CNS). The CNS includes your brain, spinal cord, and nerves. MS causes your immune system to attack and destroy the coating (myelin) that covers your nerves. Th...